The Food and Drug Administration recently approved two novel thrombopoiesis-stimulating agents, Romiplostim (AMG-531, Nplate) and Eltrombopag (Promacta), for the treatment of adults with immune ...

A 34-year-old woman (gravida 3, para 2) at 16 weeks’ gestation was found to have platelets unable to be quantified because of clumping on routine prenatal blood work, with a visual estimate of 40 ...

Neonatal alloimmune thrombocytopenia is a rare but potentially life threatening condition in newborns. It can cause bleeding in the brain and long-term effects. Treatment usually involves a platelet ...

There is a lack of evidence-based guidelines for neonatal transfusion practices as seen by the diverse RBC transfusion practices among individuals and institutions. [3,5,27,28,29,30,31,32] The US ...

February 18, 2010 — Low doses of platelets given prophylactically led to a decreased number of platelets transfused per patient but an increased number of transfusions given, according to the results ...

Neonatal alloimmune thrombocytopenia (NAIT) is a disorder that affects pregnant people and their fetuses. It occurs when the birthing parent’s immune system produces antibodies that attack and destroy ...

The use of low-dose platelet transfusion in patients undergoing hematopoietic stem-cell transplantation with platelet counts less than 10,000/mm 3 did not significantly affect bleeding compared with ...

How Does Doptelet Work in Thrombocytopenia? Thrombocytopenia is when your blood has too few platelets (also called thrombocytes). Platelets are blood cells made in the soft, spongy tissue inside your ...